Traws Pharma, Inc. Common Stock
TRAW •
Sell Open
Signal type
Sell
Status
Open
Open Price
$1.49
Stop Loss
$2.58
Performance
-6.71%
Days Open
13
Signal Setup
Signal Type Sell
Status Open
Open Date Apr 2, 2026
Open Price $1.49
Stop Loss $2.58
Timespan Day
Company Profile
Name Traws Pharma, Inc. Common Stock
Ticker TRAW
Market Cap $8.24M
Sector PHARMACEUTICAL PREPARATIONS
Latest Close $1.59
List Date Jul 25, 2013
Description
Traws Pharma Inc is a clinical-stage biopharmaceutical company dedicated to developing novel therapies to target critical threats to human health in respiratory viral diseases. It is advancing novel investigational antiviral agents that have potent activity against difficult-to-treat or resistant virus strains that threaten human health. Its product candidates are Tivoxavir marboxil, Ratutrelvir, and Narazaciclib.
Website Open Company Website